Alliance A011801 (compassHER2 RD): Postneoadjuvant T-DM1 + tucatinib/placebo in patients with residual HER2-positive invasive breast cancer

Ciara C. O'Sullivan, Karla V. Ballman, Linda McCall, Anuhya Kommalapati, Tyler Zemla, Anna Weiss, Melissa Mitchell, Victoria Blinder, Nadine M. Tung, William J. Irvin, Myounghee Lee, Matthew P. Goetz, William Fraser Symmans, Virginia F. Borges, Ian Krop, Lisa A. Carey, Ann H. Partridge

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Alliance A011801 (compassHER2 RD): Postneoadjuvant T-DM1 + tucatinib/placebo in patients with residual HER2-positive invasive breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences